2m 2m 2m 2m 2m 2m 2m
GINKGO BIO-A (DNA)
NYSE
$7.48+$0.08 (+1.08%)
Price as of Aug 21, 2026 7:48 PM EDT- $409.8MMarket Cap
- -41.04%1-Year Change
- BiotechnologyIndustry
GINKGO BIO-A (DNA)
$7.48+$0.08 (+1.08%)
DNA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.40 | ||
Change | +$0.44 (+6.32%) | ||
Open | $7.09 | ||
High | $7.42 | ||
Low | $6.82 | ||
Previous Close | $6.96 | ||
Volume | 1,437,057 | ||
30-Day Average Volume | 1,124,071 | ||
1-Week Change | 8.98% | ||
1-Month Change | -6.21% | ||
1-Year Change | -41.04% | ||
3-Year Change | -88.86% | ||
5-Year Change | -99.81% | ||
Fundamentals | |||
Shares Outstanding | 55.4M | ||
Total Assets | $990.0M | ||
Market Cap | $409.8M | ||
Enterprise Value | $325.3M | ||
Period: QTR TTM FY | |||
Revenue | $20.2M | ||
Net Income | -$46.7M | ||
Free Cash Flow | -$46.9M | ||
EBIT | -$46.6M | ||
EBITDA | -$34.3M | ||
Net Working Capital | $259.8M | ||
EPS | -$0.75 | ||
Enterprise Value/EBITDA | -9 | ||
Enterprise Value/Revenue | 16 | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 40 | ||
Last Split Date | 08/20/2024 | ||
Earnings & Revenue